Risk Consolidates, PMIs in focus Risk Consolidates, PMIs in focus Risk Consolidates, PMIs in focus

Risk Consolidates, PMIs in focus

Summary:  Overnight risk assets recuperate as oil steadies, US equities posting gains across the board off the back of stronger oil prices.

Risk began on a solid footing in the Asia trade but has since faltered as attention turns to weaker PMIs in Australia and Japan and the raft of PMIs to be released later today as well as the high stakes EUCO meeting. Aussie stocks again lagging Asian counterparts, at the time of writing Nikkei +1.36%, KOSPI +0.83%, Hang Seng +0.39%, ASX200 -0.46%.

Weakness presenting in higher beta Aussie stocks that have bounced back strongly, ahead of reporting season. The price action in oil markets this week, a market with true price discovery that has not been altered by the “unlimited” liquidity from Central Banks, warning the rapid rebound in risk assets has perhaps run its course against the real economy backdrop. The ongoing sharp contraction in both the real economy and corporate earnings leaves little margin for error at current above average valuations, which are based on likely overstated earnings estimates. As it becomes more apparent that the road to recovery and widespread testing/vaccination is long and winding, the pipedream of a mean reverting snapback in activity in the 2H becomes more distant. This calls into question the sustainability of the bounce and continues to cap sentiment. The Aussie banks continue to weigh on the index, another headwind holding back the ASX200. As we wrote earlier this week, as the outlook for the banks and their traditionally juicy dividend payments becomes cloudier, the opportunity cost of these holdings grows. Headwinds include rising consumer credit defaults and bad debts across residential mortgage books and higher impairment charges denting profits. The share prices have already corrected significantly, but there is capacity for ongoing pressure particularly as we expect dividends will likely be deferred to 0 for the first half of 2020. The panic deleveraging of Q1 may be past, but dividend cuts remain a prompt for retail selling, particularly for pensioners reliant on dividends for income. Until this uncertainty is resolved when the big four (CBA, WBC, ANZ, NAB) update the market in May, it will be hard for Aussie stocks to push much higher from these levels.

The Australia Services PMI collapsed, as the lockdown has shuttered many businesses and jobs have been lost with a frightening speed, contributing to the large drop. Flash PMIs will later be released in the US, EZ, Germany, France and the UK. Likely delivering the same cliff drop in activity as lockdowns have largely become more severe throughout April, with services leading the decline. The forward outlook subindices will be useful in gauging how quickly businesses expect activity to rebound, a useful read on the effectiveness of stimulus measures to date and the optimistic assumptions of a V-shaped recovery underpinning risk assets. 
Source: Bloomberg

WTI leapt almost 25% overnight after the June contract traded down towards $10 at one stage, helping to keep risk buoyed in the US session. Gaining after the heavy sell off and President Trump resorting to other methods to pump the oil price ordering the US Navy to destroy any Iranian gunboats that hassle US ships. However, without some resolution of the ongoing storage issues and vast over supply, we are far from out of the woods. The issue is supply and demand, oil keeps being produced and not used, and the storage problem will be in effect post the shutdown ending whilst the global economy runs below potential. Meaning we may yet relive the horrors of the May contract roll when the June contract rolls, unless those fundamental issues are resolved. The only cure will be a restart of the global economy.

Overnight the ECB eased collateral rules, now accepting sub-investment grade debt in its financing operations which has also soothed nerves into the all-important, or “make or break” as our Christopher Dembik puts it, EUCO meeting tonight. This permits the ECB to continue to finance Italian banks if Italy lost its investment-grade status, relieving some pressure in BTPs.

Keep an eye on

  • Beijing has shut down gyms once more fearing 2nd wave of infections. The risks of lockdowns easing too early, without widespread testing. We have seen the same 2nd wave in Singapore, a clear risk for some US states which are easing lockdowns and reopening very quickly whilst their daily new cases remain high. I am no epidemiologist, but anecdotally the balance of probabilities lie with opening up economies becoming a phased transition and the return to normality being slow. In that instance, it is far from likely the employment recovery will be V-shaped. This in itself creates another headwind as the negative externalities and second order implications then have the ability to cascade, presenting an additional lag on economic activity.
  • Dollar Index – DXY looks poised for a move higher, one that could dent enthusiasm for risk assets
  • Jobless claims – may decline from previous weeks although remaining at unprecedented levels

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.